Cardiac Markers in Depressed Patients With Coronary Heart Disease - R01HL147862 (TREND-3)
Fatigue, Anhedonia and Cardiac Prognostic Markers in Depressed Patients With Coronary Heart Disease
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Patricia A Herzing, RN
- Phone Number: 314-286-1360
- Email: herzingp@wustl.edu
Study Contact Backup
- Name: Jessica L Winker, MPH
- Phone Number: 314-286-1313
- Email: jessica.winker@wustl.edu
Study Locations
-
-
Missouri
-
St Louis, Missouri, United States, 63108
- Washington University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients seen at the Washington University Medical Center with coronary heart disease (CHD) documented by coronary angiography or history of acute coronary syndrome (ACS).
- On a stable medication regimen (only minor changes in drug or dosage in last 30 days) are eligible for recruitment.
- Meet the diagnostic criteria for a depressive disorder, score ≥ 14 on the Beck Depression Inventory (BDI-II), and not meet any exclusion criteria.
Exclusion Criteria:
- Thyroid disease or thyroid medications.
- Moderate to severe cognitive impairment.
- Major psychiatric comorbidities.
- Taking antidepressants other than a selective serotonin reuptake inhibitor (SSRI).
- Suicidal features.
- Current substance abuse.
- New York Heart Association (NYHA) class III or higher or a recent (<3 months) acute coronary syndrome (ACS), coronary artery bypass graft surgery, cardiac hospitalization, or cardiac-related emergency department visit.
- Advanced malignancy, a disability that would prevent compliance with the study protocol, or physician or patient refusal.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Patients with medically stable coronary heart disease and Depressive Disorder
|
Patients with Coronary Heart Disease and Depressive Disorder are receiving routine treatment by their physician.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
This is our primary measure of depression severity.
Time Frame: baseline contact
|
Beck Depression Inventory (BDI-II) scale 0-63; higher score indicates a more severe depression |
baseline contact
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Kenneth E Freedland, PhD, Washington University School of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- R01HL147862 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.